Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: Russia Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20062
20074
20081
20094
20101
20111
20122
20132
20141
20152
20164
20172
20181
20192
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S16
Mannkind Corporation5
Sanofi5
Eli Lilly and Company4
Geropharm2
Andromeda Biotech Ltd.1
AstraZeneca1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 135
Diabetes Mellitus19
Diabetes Mellitus, Type 23
Asthma2
Insulin Resistance2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.